Siamab Therapeutics is Therapeutic Devices in United States that focus on technology platform business. Founded in 2006. They cover business area such as developer, therapy, cancer, product, new biological discovery, non-human sialic acid, their dietary role, inflammatory consequence, their impact, inflammatory mediate disease, scientist, research, oncology, antibody engineering, anti-taca antibody discovery and development program.
2006
( 18 years old in 2024 )
Technology Platform
-
90 Bridge Street
Suite 100
Newton, MA 02458
United States
Private
developertherapycancerproductnew biological discoverynon-human sialic acidtheir dietary roleinflammatory consequencetheir impactinflammatory mediate diseasescientistresearchoncologyantibody engineeringanti-taca antibody discovery and development program
* We use standard office opening hours in near Siamab Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Siamab Therapeutics is Therapeutic Devices business from United States that founded in 2006 (18 years old in 2024), Siamab Therapeutics business is focusing on Technology Platform.
Siamab Therapeutics headquarter office and corporate office address is located in 90 Bridge Street Suite 100 Newton, MA 02458 United States.
Siamab Therapeutics was founded in United States.
In 2024, Siamab Therapeutics is currently focus on technology platform sector.
Above is snippet of Google Trends for "technology platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Siamab Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
